Financials Q & M Dental Group (Singapore) Limited
Equities
QC7
SG2E73981531
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.245 SGD | +2.08% | +2.08% | -3.92% |
06-13 | Q&M Dental Provides Clarification to Business Time Article on Scaling Procedures | MT |
06-04 | Q&M Dental Group (Singapore) Enters Share Placement Agreement with Three Placees | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 377.1 | 370 | 568.4 | 298.1 | 241.3 | 231.9 | - | - |
Enterprise Value (EV) 1 | 377.1 | 370 | 604.5 | 343.5 | 287.6 | 268.9 | 270 | 231.9 |
P/E ratio | 21 x | 18.8 x | 18.7 x | 26.3 x | 20.9 x | 16.3 x | 14.6 x | 14.8 x |
Yield | - | 1.91% | 5.95% | 3.17% | 2.71% | 3.76% | 4.07% | 6.53% |
Capitalization / Revenue | 2.95 x | 2.69 x | 2.76 x | 1.65 x | 1.32 x | 1.23 x | 1.21 x | 1.13 x |
EV / Revenue | 2.95 x | 2.69 x | 2.94 x | 1.9 x | 1.57 x | 1.42 x | 1.41 x | 1.13 x |
EV / EBITDA | - | 12.5 x | 12.1 x | 14.5 x | 11.7 x | 9.1 x | 7.83 x | 7.29 x |
EV / FCF | - | 19.1 x | 14.1 x | 15.2 x | - | 10.1 x | 9.49 x | 8.67 x |
FCF Yield | - | 5.25% | 7.1% | 6.57% | - | 9.87% | 10.5% | 11.5% |
Price to Book | - | 3.06 x | 5.81 x | 3.09 x | 2.35 x | 2.13 x | 1.94 x | 2.23 x |
Nbr of stocks (in thousands) | 942,750 | 944,774 | 939,443 | 946,443 | 946,443 | 946,443 | - | - |
Reference price 2 | 0.4000 | 0.3917 | 0.6050 | 0.3150 | 0.2550 | 0.2450 | 0.2450 | 0.2450 |
Announcement Date | 15/04/20 | 28/02/21 | 22/02/22 | 01/03/23 | 29/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 128 | 137.6 | 205.6 | 181.2 | 182.7 | 189.1 | 191.3 | 205.6 |
EBITDA 1 | - | 29.63 | 50.12 | 23.61 | 24.48 | 29.56 | 34.47 | 31.8 |
EBIT 1 | - | 26.18 | 45.99 | 18.72 | 19.4 | 24.28 | 24.82 | 26.4 |
Operating Margin | - | 19.02% | 22.37% | 10.33% | 10.62% | 12.84% | 12.98% | 12.84% |
Earnings before Tax (EBT) 1 | - | 22.37 | 46.65 | 14.28 | 13.66 | 17.2 | 18.93 | 20.09 |
Net income 1 | - | 19.7 | 30.47 | 11.31 | 11.52 | 14.21 | 15.67 | 16.74 |
Net margin | - | 14.32% | 14.82% | 6.24% | 6.3% | 7.52% | 8.19% | 8.14% |
EPS 2 | 0.0191 | 0.0208 | 0.0323 | 0.0120 | 0.0122 | 0.0150 | 0.0168 | 0.0165 |
Free Cash Flow 1 | - | 19.41 | 42.93 | 22.58 | - | 26.54 | 28.46 | 26.75 |
FCF margin | - | 14.11% | 20.88% | 12.46% | - | 14.03% | 14.88% | 13.01% |
FCF Conversion (EBITDA) | - | 65.51% | 85.65% | 95.62% | - | 89.79% | 82.57% | 84.12% |
FCF Conversion (Net income) | - | 98.53% | 140.88% | 199.65% | - | 186.71% | 181.58% | 159.84% |
Dividend per Share 2 | - | 0.007500 | 0.0360 | 0.0100 | 0.006900 | 0.009200 | 0.009980 | 0.0160 |
Announcement Date | 15/04/20 | 28/02/21 | 22/02/22 | 01/03/23 | 29/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 |
---|---|
Net sales 1 | 87.14 |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income | - |
Net margin | - |
EPS | - |
Dividend per Share | - |
Announcement Date | 14/08/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | 36.1 | 45.4 | 46.3 | 37 | 38.1 | - |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.7206 x | 1.921 x | 1.891 x | 1.252 x | 1.105 x | - |
Free Cash Flow 1 | - | 19.4 | 42.9 | 22.6 | - | 26.5 | 28.5 | 26.8 |
ROE (net income / shareholders' equity) | - | 16.2% | 27.8% | 11.6% | 11.2% | 13.9% | 14.3% | 15.1% |
ROA (Net income/ Total Assets) | - | 6.8% | 11.1% | 6.08% | 5.49% | 5.91% | 6.38% | 7.36% |
Assets 1 | - | 289.8 | 275.5 | 186.1 | 209.8 | 240.4 | 245.8 | 227.4 |
Book Value Per Share 2 | - | 0.1300 | 0.1000 | 0.1000 | 0.1100 | 0.1200 | 0.1300 | 0.1100 |
Cash Flow per Share | - | - | 0.0500 | 0.0400 | - | - | - | - |
Capex 1 | - | 6.39 | 7.87 | 11 | 9.31 | 6.13 | 6.55 | 6.31 |
Capex / Sales | - | 4.64% | 3.83% | 6.06% | 5.1% | 3.24% | 3.42% | 3.07% |
Announcement Date | 15/04/20 | 28/02/21 | 22/02/22 | 01/03/23 | 29/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.92% | 171M | |
+25.21% | 88.77B | |
-22.28% | 77.04B | |
+5.63% | 26.87B | |
-9.70% | 17.3B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
-23.68% | 13.16B | |
+70.99% | 13.15B | |
+77.65% | 13.11B |
- Stock Market
- Equities
- QC7 Stock
- Financials Q & M Dental Group (Singapore) Limited